Company profile: Tentarix
1.1 - Company Overview
Company description
- Provider of protein therapeutics and discovery platforms leveraging synthetic biology, including the Tentacles platform for multifunctional, conditionally active antibody-based biologics that activate immune cells and modulate disease while minimizing safety concerns; CellSurf to understand cell surface proteomes; HuTARG mammalian display to discover fully human binders; and FunctionSeq high-throughput screening of multifunctional biologics.
Products and services
- Tentacles™ Platform: Engineers multifunctional, conditionally-active antibody-based biologics to activate immune cells and modulate disease pathways while minimizing safety concerns using uniquely combined bioactivities
- FunctionSeq™: Architects high-throughput screening to create and screen millions of multifunctional biologics, identifying specific agonists with optimal activity and precise cell specificity
- HuTARG™: Constructs a mammalian display system leveraging the human immune system to discover fully human binders using a vast library of unique VH domains
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tentarix
Merlin Diagnostika
HQ: Germany
Website
- Description: Provider of microbiological diagnostics solutions, developing and producing products for automated identification and susceptibility determination of bacteria and yeasts. Serves domestic routine laboratories in human and veterinary fields and has an international customer base.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Merlin Diagnostika company profile →
Double Bond Pharmaceutical
HQ: Sweden
Website
- Description: Provider of first-in-class pharmaceutical therapies and drug delivery solutions for cancers, infections, autoimmune diseases and other life-threatening disorders. Offers the BeloGal biomimetic encapsulation platform and pipeline candidates including SI-053 for brain cancer, SA-033 targeting doxorubicin to the liver, and Belopenem directing meropenem to infected lungs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Double Bond Pharmaceutical company profile →
Jena Bioscience
HQ: Germany
Website
- Description: Provider of biotechnology products, including isothermal amplification and LAMP products for rapid DNA/RNA analysis, ready-to-use lyophilized PCR mixes in 96-well plates, contamination detection controls for food, cell cultures and nucleic acids, RNA/DNA preparation and cleanup kits with magnetic bead options, and click reagents for lipid and posttranslational modification analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jena Bioscience company profile →
Iota Sciences
HQ: United Kingdom
Website
- Description: Provider of cell biology discovery technologies, including a Cloning Platform that gently handles single cells and uses less culture medium to produce verified clonal cultures, a scPicking Platform utilizing low-volume cell chambers to isolate single cells for transfer to downstream formats, and hiPSC gene-editing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Iota Sciences company profile →
DiscoverX
HQ: United States
Website
- Description: Provider of reagents, complete cell-based assay kits, profiling and screening services, and other turn-key solutions for the drug discovery, screening, and life science markets, offering biochemical and cell-based assays to improve research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DiscoverX company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tentarix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tentarix
2.2 - Growth funds investing in similar companies to Tentarix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tentarix
4.2 - Public trading comparable groups for Tentarix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →